|
1
|
Reardon DA, Galanis E, DeGroot JF, et al:
Clinical trial end points for high-grade glioma: the evolving
landscape. Neuro Oncol. 13:353–361. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Recławowicz D, Stempniewicz M, Biernat W
and Słoniewski P: Modern approach to WHO grade II glioma
classification and treatment – review of the literature. Neurol
Neurochir Pol. 42:536–545. 2008.PubMed/NCBI
|
|
3
|
Mitlianga PG, Sioka C, Vartholomatos G, et
al: p53 enhances the Delta-24 conditionally replicative adenovirus
anti-glioma effect. Oncol Rep. 15:149–153. 2006.PubMed/NCBI
|
|
4
|
Wang X, Han L, Zhang A, et al:
Adenovirus-mediated shRNAs for co-repression of miR-221 and miR-222
expression and function in glioblastoma cells. Oncol Rep.
25:97–105. 2011.PubMed/NCBI
|
|
5
|
Zhang K, Zhang J, Han L, Pu P and Kang C:
Wnt/beta-catenin signaling in glioma. J Neuroimmune Pharmacol.
7:740–749. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Clevers H and Nusse R: Wnt/β-catenin
signaling and disease. Cell. 149:1192–1205. 2012.
|
|
7
|
Kamino M, Kishida M, Kibe T, et al: Wnt-5a
signaling is correlated with infiltrative activity in human glioma
by inducing cellular migration and MMP-2. Cancer Sci. 102:540–548.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gotze S, Wolter M, Reifenberger G, Muller
O and Sievers S: Frequent promoter hypermethylation of Wnt pathway
inhibitor genes in malignant astrocytic gliomas. Int J Cancer.
126:2584–2593. 2010.PubMed/NCBI
|
|
9
|
Pu P, Zhang Z, Kang C, et al:
Downregulation of Wnt2 and beta-catenin by siRNA suppresses
malignant glioma cell growth. Cancer Gene Ther. 16:351–361. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang X, Abreu JG, Yokota C, et al: Tiki1
is required for head formation via Wnt cleavage-oxidation and
inactivation. Cell. 149:1565–1577. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xia H, Cheung WK, Ng SS, et al: Loss of
brain-enriched miR-124 microRNA enhances stem-like traits and
invasiveness of glioma cells. J Biol Chem. 287:9962–9971. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
He X, Liu J, Yang C, et al: 5/35
fiber-modified conditionally replicative adenovirus armed with p53
shows increased tumor-suppressing capacity to breast cancer cells.
Hum Gene Ther. 22:283–292. 2011. View Article : Google Scholar
|
|
13
|
Westphal M, Ylä-Herttuala S, Martin J, et
al: Adenovirus-mediated gene therapy with sitimagene ceradenovec
followed by intravenous ganciclovir for patients with operable
high-grade glioma (ASPECT): a randomised, open-label, phase 3
trial. Lancet Oncol. 14:823–833. 2013. View Article : Google Scholar
|
|
14
|
Tobias A, Ahmed A, Moon KS and Lesniak MS:
The art of gene therapy for glioma: a review of the challenging
road to the bedside. J Neurol Neurosurg Psychiatry. 84:213–222.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu XL, Zhao D, Sun DP, et al:
Adenovirus-mediated delivery of CALR and MAGE-A3 inhibits invasion
and angiogenesis of glioblastoma cell line U87. J Exp Clin Cancer
Res. 31:82012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li X, Mao Q, Wang D, Zhang W and Xia H: A
fiber chimeric CRAd vector Ad5/11-D24 double-armed with TRAIL and
arresten for enhanced glioblastoma therapy. Hum Gene Ther.
23:589–596. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu J, Xu X, Feng X, Zhang B and Wang J:
Adenovirus-mediated delivery of bFGF small interfering RNA reduces
STAT3 phosphorylation and induces the depolarization of
mitochondria and apoptosis in glioma cells U251. J Exp Clin Cancer
Res. 30:802011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bo Y, Guo G and Yao W: MiRNA-mediated
tumor specific delivery of TRAIL reduced glioma growth. J
Neurooncol. 112:27–37. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao Y, Li Y, Wang L, et al: microRNA
response elements-regulated TRAIL expression shows specific
survival-suppressing activity on bladder cancer. J Exp Clin Cancer
Res. 32:102013. View Article : Google Scholar
|
|
20
|
Liu J, Ma L, Li C, et al: Tumor-targeting
TRAIL expression mediated by miRNA response elements suppressed
growth of uveal melanoma cells. Mol Oncol. 2013.PubMed/NCBI
|
|
21
|
Ma L, Liu J, Shen J, et al: Expression of
miR-122 mediated by adenoviral vector induces apoptosis and cell
cycle arrest of cancer cells. Cancer Biol Ther. 9:554–561. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ma S, Liang S, Jiao H, et al: Human
umbilical cord mesenchymal stem cells inhibit C6 glioma growth via
secretion of dickkopf-1 (DKK1). Mol Cell Biochem. 2013.PubMed/NCBI
|
|
23
|
Wang B, Liu J, Ma LN, et al: Chimeric 5/35
adenovirus-mediated Dickkopf-1 overexpression suppressed
tumorigenicity of CD44+ gastric cancer cells via
attenuating Wnt signaling. J Gastroenterol. 48:798–808. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hoffmann D, Meyer B and Wildner O:
Improved glioblastoma treatment with Ad5/35 fiber chimeric
conditionally replicating adenoviruses. J Gene Med. 9:764–778.
2007. View
Article : Google Scholar
|
